Oryzon Genomics S.A. (BME:ORY)
Spain
· Delayed Price · Currency is EUR 3.200
-0.050 (-1.54%)
At close: Dec 5, 2025
Oryzon Genomics Employees
Oryzon Genomics had 47 employees as of December 31, 2024. The number of employees increased by 1 or 2.17% compared to the previous year.
Employees
47
Change (1Y)
1
Growth (1Y)
2.17%
Revenue / Employee
€156,570
Profits / Employee
€58,639
Market Cap
252.33M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 23,833 |
| Laboratorios Farmaceuticos Rovi | 2,197 |
| Almirall | 2,026 |
| Faes Farma | 1,775 |
| Pharma Mar | 500 |
| Clínica Baviera | 1,759 |
| Prim, S.A. | 958 |
| Laboratorio Reig Jofre | 1,437 |
Oryzon Genomics News
- 4 months ago - ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025 - Benzinga
- 7 months ago - Oryzon Genomics S.A. GAAP EPS of -$0.03 - Seeking Alpha
- 10 months ago - Oryzon Genomics S.A. GAAP EPS of -$0.02 - Seeking Alpha
- 11 months ago - ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders' Meeting - Benzinga